(Q38033591)

27 August 2017

title

Oncolytic virotherapy with modified adenoviruses and novel therapeutic targets (English)

1 reference

27 August 2017

1 reference

1 reference

Gunnel Halldén

1

1 reference

27 August 2017

Giuseppe Portella

series ordinal

2

1 reference

27 August 2017

language of work or name

English

0 references

publication date

13 August 2012

1 reference

Expert Opinion on Therapeutic Targets

27 August 2017

published in

1 reference

27 August 2017

volume

16

1 reference

27 August 2017

issue

10

1 reference

27 August 2017

page(s)

945-958

1 reference

Recent progress in the battle between oncolytic viruses and tumours

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

The RB and p53 pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Mechanisms of apoptosis regulation by viral oncogenes in infection and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

A phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Regression of Burkitt's lymphoma in association with measles infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Treatment of human cancer with mumps virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Clinical studies of viruses as antineoplastic agents with particular reference to Egypt 101 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Newcastle disease virus (NDV): brief history of its oncolytic strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

The ADA human gene therapy clinical protocol: Points to Consider response with clinical protocol, July 6, 1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Engineering targeted viral vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

A cyclooxygenase-2 promoter-based conditionally replicating adenovirus with enhanced infectivity for treatment of ovarian adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Identifying the safety profile of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in anticipation of a phase I clinical trial in patients with recurrent ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

China approves world's first oncolytic virus therapy for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Adenovirus overrides cellular checkpoints for protein translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

A phase I study of a tropism-modified conditionally replicative adenovirus for recurrent malignant gynecologic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Oncolytic adenovirus ICOVIR-7 in patients with advanced and refractory solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Improved potency and selectivity of an oncolytic E1ACR2 and E1B19K deleted adenoviral mutant in prostate and pancreatic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

The hTERT promoter enhances the antitumor activity of an oncolytic adenovirus under a hypoxic microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Enhanced oncolysis by a tropism-modified telomerase-specific replication-selective adenoviral agent OBP-405 ('Telomelysin-RGD').

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

OPTIM trial: a Phase III trial of an oncolytic herpes virus encoding GM-CSF for unresectable stage III or IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Systemic armed oncolytic and immunologic therapy for cancer with JX-594, a targeted poxvirus expressing GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

A mechanistic proof-of-concept clinical trial with JX-594, a targeted multi-mechanistic oncolytic poxvirus, in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Sequential therapy with JX-594, a targeted oncolytic poxvirus, followed by sorafenib in hepatocellular carcinoma: preclinical and clinical demonstration of combination efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Reovirus therapy of tumors with activated Ras pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Reovirus therapy stimulates endoplasmic reticular stress, NOXA induction, and augments bortezomib-mediated apoptosis in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Development and assessment of human adenovirus type 11 as a gene transfer vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

A new generation of serotype chimeric infectivity-enhanced conditionally replicative adenovirals: the safety profile of ad5/3-Δ24 in advance of a phase I clinical trial in ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Serotype chimeric human adenoviruses for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

The influence of blood on in vivo adenovirus bio-distribution and transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Adenovirus serotype 5 hexon mediates liver gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

HPMA copolymers for masking and retargeting of therapeutic viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

In vitro evaluation of a 'stealth' adenoviral vector for targeted gene delivery to adult mammalian neurones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

An oncolytic adenovirus defective in pRb-binding (dl922-947) can efficiently eliminate pancreatic cancer cells and tumors in vivo in combination with 5-FU or gemcitabine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

The oncolytic adenovirus AdΔΔ enhances selective cancer cell killing in combination with DNA-damaging drugs in pancreatic cancer models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Inhibition of autophagy enhances the effects of E1A-defective oncolytic adenovirus dl922-947 against glioma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Efficacy of oncolytic mutants targeting pRb and p53 pathways is synergistically enhanced when combined with cytotoxic drugs in prostate cancer cells and tumor xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Bevacizumab increases viral distribution in human anaplastic thyroid carcinoma xenografts and enhances the effects of E1A-defective adenovirus dl922-947.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

AZD1152 negatively affects the growth of anaplastic thyroid carcinoma cells and enhances the effects of oncolytic virus dl922-947.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Combination of gemcitabine and Ad5/3-Delta24, a tropism modified conditionally replicating adenovirus, for the treatment of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Activity of the adenoviral E1A deletion mutant dl922-947 in ovarian cancer: comparison with E1A wild-type viruses, bioluminescence monitoring, and intraperitoneal delivery in icodextrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Oncolytic adenoviral mutants with E1B19K gene deletions enhance gemcitabine-induced apoptosis in pancreatic carcinoma cells and anti-tumor efficacy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

An E1B-19 kDa gene deletion mutant adenovirus demonstrates tumor necrosis factor-enhanced cancer selectivity and enhanced oncolytic potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

The 19-Kilodalton Adenovirus E1B Transforming Protein Inhibits Programmed Cell Death and Prevents Cytolysis by Tumor Necrosis Factor α

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Regulation of the cell cycle and apoptosis by the oncogenes of adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

E1A-expressing adenoviral E3B mutants act synergistically with chemotherapeutics in immunocompetent tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Five-year follow-up of trial of replication-competent adenovirus-mediated suicide gene therapy for treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Oncolytic virotherapy for ovarian carcinomatosis using a replication-selective vaccinia virus armed with a yeast cytosine deaminase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Drug penetration in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Hypoxia reduces adenoviral replication in cancer cells by downregulation of viral protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Impact of tumor microenvironment on oncolytic viral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Intratumoral coadministration of hyaluronidase enzyme and oncolytic adenoviruses enhances virus potency in metastatic tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Human matrix metalloproteinase-8 gene delivery increases the oncolytic activity of a replicating adenovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Novel three-pronged strategy to enhance cancer cell killing in glioblastoma cell lines: histone deacetylase inhibitor, chemotherapy, and oncolytic adenovirus dl520.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

HDAC inhibitor valproic acid enhances tumor cell kill in adenovirus-HSVtk mediated suicide gene therapy in HNSCC xenograft mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Lovastatin enhances the replication of the oncolytic adenovirus dl1520 and its antineoplastic activity against anaplastic thyroid carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Conditionally replicating adenoviruses kill tumor cells via a basic apoptotic machinery-independent mechanism that resembles necrosis-like programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

E1B55K-deleted adenovirus (ONYX-015) overrides G1/S and G2/M checkpoints and causes mitotic catastrophe and endoreduplication in p53-proficient normal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Autophagy: dual roles in life and death?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Cell death: a dynamic response concept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Autophagy in immunity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Viral interactions with macroautophagy: a double-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

The autophagy machinery is required to initiate hepatitis C virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Knockdown of autophagy-related gene decreases the production of infectious hepatitis C virus particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Linking dengue virus entry and translation/replication through amphisomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Human adenovirus type 5 induces cell lysis through autophagy and autophagy-triggered caspase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Autophagy-inducing agents augment the antitumor effect of telerase-selve oncolytic adenovirus OBP-405 on glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

The E1B19K oncoprotein complexes with Beclin 1 to regulate autophagy in adenovirus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Choreography of the DNA damage response: spatiotemporal relationships among checkpoint and repair proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Oncolytic viruses in radiation oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

The DNA Damage Response: Making It Safe to Play with Knives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Cell cycle checkpoints: preventing an identity crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Using or abusing: viruses and the cellular DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

The life and death of DNA-PK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Synergistic combinations of signaling pathway inhibitors: mechanisms for improved cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

Targeting pediatric cancer stem cells with oncolytic virotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.712962

10.1517/14728222.2012.712962

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference